Information was received from a healthcare provider (hcp) regarding a patient receiving an unknown intrathecal medication via an implanted pump for non-malignant pain.Compatibility guidelines were requested for mri.It was unknown if the procedure was due to a problem with the device or therapy.The mri technician reported they thought she understood that the patient said they have not been receiving drugs and the pump was stalled.The hcp was trying to wean the patient off of the drugs to replace the pump with a stimulation device.The event date was asked and unknown.Additional information was received from the manufacturer's representative (rep) on (b)(6) 2018.The drugs being delivered were 4,40 0 mcg/ml fentanyl, 16 mg/ml hydromorphone, and 24 mg/ml bupivacaine, all at minimum rate dosages.It was reported that there was an empty pump.The caller does have access to the pt/8840.The reason for the call was that they were with the patient checking their pump post-mri and they were not seeing a motor stall or a motor stall recovery message.The caller stated that the pump was currently in minimum rate.It was reviewed that it is possible for the pump not to detect a motor stall due to the low flow rate.The caller stated that the pump was put in minimum rate on (b)(6) 2018 when that patient went in to the healthcare professional (hcp) due to not having medication in the pump.The event date was reported as 2017, ¿sometime during the holidays last year.¿ they put the pump in minimum rate and are weaning the patient off so they can explant the pump.It was confirmed that ¿there are no issues with the pump, the patient just no longer wants the pump anymore.¿ there were no symptoms reported.There were no further complications reported/anticipated.
|